What does Serina Therapeutics, Inc. do?
Serina Therapeutics, Inc., a biotechnology company, develops drugs to treat neurological diseases and pain. Its lead product candidate is SER 252 (POZ-apomorphine), a POZ conjugate for the treatment of advanced Parkinson's disease that is in phase 1 clinical trial; and POZ-lipids, a non-immunogenic alternative to the…
What is Serina Therapeutics, Inc.'s P/E and P/B ratio?
Serina Therapeutics, Inc. has a P/E ratio of -0.9 and a P/B ratio of 2.39.
What is Serina Therapeutics, Inc.'s debt-to-equity ratio?
Serina Therapeutics, Inc. has a debt-to-equity ratio of 0.20.
How much does Serina Therapeutics, Inc. owe compared with what it owns?
Serina Therapeutics, Inc. owes $0.27 for every $1 it owns (balance sheet Jun 2026), which is low.
What is Serina Therapeutics, Inc.'s Positivity rank?
Serina Therapeutics, Inc. is ranked #2,748 of 6,774 companies globally and #971 of 4,000 in United States on PositoAI, with a Positivity Score of 21,172.
Does Serina Therapeutics, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
Yes. Serina Therapeutics, Inc. has 1 active red flag (PosiRed) on record: Stock exchange listing-rule deficiency notice (8-K Item 3.01) (dated 15 Jan 2026). It has no yellow flags.
Where can I read the latest news about Serina Therapeutics, Inc.?
Recent headlines about Serina Therapeutics, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Serina Therapeutics, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Serina Therapeutics, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.